Literature DB >> 16182009

Hyperacute measurement of brain-tissue oxygen, carbon dioxide, pH, and intracranial pressure before, during, and after cerebral angiography in patients with aneurysmatic subarachnoid hemorrhage in poor condition.

Mario Carvi y Nievas1, Selim Toktamis, Hans-Georg Höllerhage, Eberhard Haas.   

Abstract

BACKGROUND: The objective of this study was to examine early changes of intracranial pressure (ICP) and brain oxygenation before, during, and after cerebral angiography in patients with poor-grade subarachnoid hemorrhage (SAH).
METHODS: Fourteen patients with poor-grade SAH without intracerebral hematoma were studied. A significant change in monitored variables (arterial gases, ICP, brain-tissue oxygen pressure [Ptio(2)], brain-tissue carbon dioxide pressure, and pH) was defined as a register deviation of more than 20% compared with the baseline. Critical Ptio(2) values (<15 mm Hg) or significant Ptio(2) decreases were considered to be impaired brain oxygenation. These data were correlated with the angiography findings and the presence of massive brain edema and hypodense areas in follow-up computed tomography (CT) scan controls.
RESULTS: Neurotrend data were unavailable in 4 patients because of calibration failure. Impaired brain oxygenation during angiography was observed in 5 patients. Initial critical Ptio(2) values were found in 1 patient. Four patients developed a linear Ptio(2) and pH decrease after the angio-catheter canalized the examined vessels in the neck. Statistically significant correlation was found between brain pH and Ptio(2) changes in these patients (P < .001, Spearman rho). Arterial gases, ICP, and cerebral perfusion pressure did not show significant alterations at this time. Significant correlations existed between severe intracranial angiographic arterial caliber reduction and impaired Ptio(2) values (P < .01). Patients with impaired Ptio(2) values frequently showed lesions in CT scan controls (P < .05).
CONCLUSIONS: This study documented several fluctuations in the brain oxygenation of patients with poor-grade SAH during angiography. Patients with severe intracranial angiographic arterial caliber reduction at this time have an increased risk for impaired brain oxygenation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16182009     DOI: 10.1016/j.surneu.2005.02.008

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  7 in total

Review 1.  Direct cerebral oxygenation monitoring--a systematic review of recent publications.

Authors:  Erhard W Lang; Jamin M Mulvey; Yugan Mudaliar; Nicholas W C Dorsch
Journal:  Neurosurg Rev       Date:  2007-01-13       Impact factor: 3.042

Review 2.  Monitoring and detection of vasospasm II: EEG and invasive monitoring.

Authors:  Daniel Hänggi
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

3.  Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage.

Authors:  Pedro Kurtz; J Michael Schmidt; Jan Claassen; Emmanuel Carrera; Luis Fernandez; Raimund Helbok; Mary Presciutti; R Morgan Stuart; E Sander Connolly; Neeraj Badjatia; Stephan A Mayer; Kiwon Lee
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

Review 4.  Methods of monitoring brain oxygenation.

Authors:  Ursula K Rohlwink; Anthony A Figaji
Journal:  Childs Nerv Syst       Date:  2010-04       Impact factor: 1.475

Review 5.  Antioxidant Melatonin: Potential Functions in Improving Cerebral Autoregulation After Subarachnoid Hemorrhage.

Authors:  Zhen-Ni Guo; Hang Jin; Huijie Sun; Yingkai Zhao; Jia Liu; Hongyin Ma; Xin Sun; Yi Yang
Journal:  Front Physiol       Date:  2018-08-17       Impact factor: 4.566

6.  Acute management of poor condition subarachnoid hemorrhage patients.

Authors:  Archavlis Eleftherios; Mario Nazareno Carvi y Nievas
Journal:  Vasc Health Risk Manag       Date:  2007

7.  The critical care management of poor-grade subarachnoid haemorrhage.

Authors:  Airton Leonardo de Oliveira Manoel; Alberto Goffi; Tom R Marotta; Tom A Schweizer; Simon Abrahamson; R Loch Macdonald
Journal:  Crit Care       Date:  2016-01-23       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.